Suresh Senan
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 278 publications
The limits of pooled evidence in early-stage NSCLC: are we comparing treatments or patients?
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 25, 2026
Corrigendum to 'Patient-Reported Outcomes With Consolidation Durvalumab Versus Placebo After Concurrent Chemoradiotherapy in Limited-Stage SCLC: Results From the Phase 3 ADRIATIC Trial' [Journal of Thoracic Oncology volume 21 issue 6 (2026) 103564].
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 24, 2026
Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in patients with metastatic NSCLC: the phase II RECLAIM trial.
Journal: Journal for immunotherapy of cancer
Published: June 03, 2026
Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 26, 2026
Efficacy and safety of adrenalectomy and stereotactic ablative radiotherapy (SABR) for adrenal metastases: A systematic review and meta-analysis.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: March 22, 2026
The survival impact of combining radiotherapy and immune checkpoint inhibitors in patients with solid tumors: A systematic review and living meta-analysis of randomized controlled trials.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 17, 2026
Assessing actionable radiological features on serial CT images in Post-SABR patients with resected local recurrence of colorectal lung metastases.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: February 16, 2026
In the Chemoimmunotherapy Era, There Is Still a Role for Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 31, 2026
Inconsistent definitions of local control for stereotactic body radiation therapy for early-stage lung cancer - A systematic review.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: January 26, 2026
Outcomes of stereotactic ablative radiotherapy or surgery for early-stage lung cancer in patients with interstitial lung disease.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: January 14, 2026
Durvalumab Consolidation in Limited-Stage SCLC: Outcomes by Prior Concurrent Chemoradiotherapy and Prophylactic Cranial Irradiation in the Phase 3 ADRIATIC Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 04, 2025
Durvalumab Consolidation Treatment Following Concurrent Chemoradiotherapy in Limited-Stage SCLC: ADRIATIC China Subgroup Analysis.
Journal: JTO clinical and research reports
Published: November 07, 2025
Last Updated: 09/26/2026